Impact Factor
2.86
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
1.11
1,644 total citations
h5-index
40
h5 depth signal
Cited share
23.9%
374 of 1,563
Total citations
1,644
Citation footprint
Metric signal
1.33
External metric anchor
Self-citation
5.7%
94 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
549
China
222
Canada
122
United Kingdom
120
Italy
120
Citing Fields of Research
Stem Cell Biology
3,263
Immunology
1,967
Hematology
850
Immunotherapy
765
Cell Biology
458
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
10,051
Articles tracked across the journal lifetime
Indexed publication set
1,563
374 cited publications
Last 12 months
899
74.9 publications/month
Open access share
9.5%
85 OA publications in the last year
Leading citing country
United States
549 citing publications
Leading citing field
Stem Cell Biology
3,263 citing publications
Latest tracked publication
15 October 2026
10 recent records available
Coverage & Indexing History
v1n1, 1999-
v1n1, 1999-
Active Coverage
Research Focus & Classification
Indexed Subjects
Stem Cell Biology
Immunology
Hematology
Issuing & Sponsoring Bodies
Contributor
International Society for Hematotherapy and Graft Engineering
Contributor
International Society for Cellular Therapy
Broad Categories
Cell Biology
Therapeutics
Stem Cell Biology
Hematology
Immunology
Noncoding RNA
MeSH Descriptors
Cell Transplantation
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1016/j.jcyt.2026.103037
Open DOI
Cytokine-Independent Proliferation of CAR-T cells: Bug or Feature?
02
03
DOI 10.1016/j.jcyt.2026.103038
Open DOI
A call to action: Position papers from the FDA Cell Therapy Liaison Meeting (CTLM) Working Group
04
DOI 10.1016/j.jcyt.2026.103035
Open DOI
Clinical trials with Advanced Therapy Medicinal Products in Europe (2016–2025): the Regulators’ analysis
05
06
DOI 10.1016/s1465-3249(26)00981-3
Open DOI
Subscription information
07
DOI 10.1016/s1465-3249(26)00980-1
Open DOI
Table of Contents
08
DOI 10.1016/s1465-3249(26)00979-5
Open DOI
Editorial Board
09
DOI 10.1016/s1465-3249(26)00978-3
Open DOI
Aims and Scope
10
Bibliographical & Catalog Notes
Title from cover.
Also issued online.
Official journal of the International Society for Hematotherapy and Graft Engineering, 1999-2001; of the International Society for Cellular Therapy, 2002- .